The consideration one feels to be lacking from the analysis by Welborn et al. of factors associated with the clinical appearance of macrovascular disease in Caucasoid diabetic patients [1] is that of the plasma insulin levels. In Type II (maturity-type onset) diabetics there is a correlation between the plasma concentrations of glucose and insulin, and this may be why there is a weak correlation with glucose in the data presented, which one can hypothesise to have been much stronger with insulin. Consideration of the plasma insulin level was also surprisingly little emphasised in the anguished analysis by Jarrett [2] of the increased amount of cardiac disease in diabetics; so many things are set out so clearly there, but the overall confusion could have been clarified by consideration of the plasma insulin levels, if the facts were available and are indeed as one suspects.
It seems reasonable to attempt such an assessment because of the association between raised insulin levels (even allowing for the degree of obesity) and the development of heart disease in three substantial prospective studies of general populations [3] [4] [5] , as well as developing evidence that hyperinsulinaemia is related to cardiac deterioration in diabetics both in Finland and England [6, 7] . 
Reply from the authors
Dear Sir, Most would agree with Dr. Hockaday's sentiment that studies of the possible association of hyperinsulinaemia with macrovascular disease are extremely relevant, especially since conventional treatments for diabetes apart from dietary regimes and exercise are likely to elevate serum insulin levels. In our recent cross-sectional study of diabetic subjects the effort and expense ofmeasuringfreeinsulin levels were not appropriate, bearing in mind the uncontrolled aspects of collecting "casual" blood samples without reference to the timing of meals of medications.
There is an enigma in this area in that the three general populations cited by Hockaday as showing an association between hyperinsulinaemia and subsequent coronary heart disease were all male. Our Busselton study gives the only information on a general population of females and there was no such association found. Recently we have re-worked the data from two separate Busselton cohorts (1966 and 1969) using survival analysis and we cannot find any trend whatsoever relating hyperinsulinaemia to cardiovascular disease end-points in females (unpublished). The Guy's Hospital team [1] have ventured an explanation for this sex difference. The situation may well be different in a population of diabetic females.
Perhaps a further prospective diet-heart study is required, along the lines of the Leiden Intervention Trial [2] , with a quantitative assessment of coronary lesion progression in relation to prevailing free insulin levels in a comparatively small number of diabetic patients ? to those reported by Worth et al. [1] . On the other hand, no significant changes of Hb A~o during normal pregnancy and no difference between Hb Aac in pregnant and non-pregnant healthy women were observed in our study [2] . In puerperium (3 months after delivery) Hb A1~ was significantly higher than during pregnancy (p < 0.001) and in nonpregnant controls (p < 0.05), respectively [2] .
We agree with the conclusion of Worth et al., that the use of any measurement of glycosylated haemoglobins in pregnancy should take account of pregnancy-specific normal ranges, each laboratory having it's own reference values. Moreover, the measurement of Hb A~o in assessing long-term glycaemic control seems to be preferable to that of Hb A1 especially during pregnangy [2, 5] , and comparison between these two parameters should be made with caution. Recently, we have employed an improved method for measuring Hb Aa~ by rapid fully automated high-performance liquid chromatography, which also determines Hb F, HB AI~, Hb Alb and Hb A2 [6] . Thus the method both detects a recent fetomaternal blood transfer, and eliminates the problem of erroneously high glycosylated haemoglobin values due to this phenomenon.
Glycosylated haemoglobins in normal pregnancy
Yours sincerely, K. Ylinen, U-H. Stenman, R. Hekali, T. Kes~iniemi-Kuokkanen and K. Teramo Dear Sir,
We read with interest the report by Worth et al. on glycosylated haemoglobin in normal pregnancy [1] . However, when comparing our results [2] with their own, the authors missed a crucial point: in our longitudinal study, we did not report the levels of total glycosylated haemoglobin (Hb A1), but those of the subfraction haemoglobin Ale (Hb Ago), which is, at least theoretically; a more reliable indicator of long-term glycaemia than Hb A1 [3] . The cation exchange chromatographic macrocolumn method used in our study [2] also permitted measurement of the minor fast haemoglobin components. The values of Hb A1 can be calculated as the sum of these fractions (Hb Ale plus the minor fast haemoglobins). Because fetal haemoglobin (Hb F) coelutes with Hb Ale in this method, as it does with Hb A1 in the cation exchange method employed by Worth et al. [1] (Bio-Rad Hemoglobin A1 by column test, Bio-Rad Laboratories, Richmond, California, USA), we also reported the levels of Hb F [2] measured by the method of Betke et al. [4] . The changes of corrected levels of Hb A1 (the apparent Hb Aa levels minus Hb F) are shown in Figure 1 , and were similar Harrison et al. have demonstrated for the first time on isolated human islets the sigmoidal nature of glucose-stimulated insulin release and its correlation with enhanced glucose oxidation [1] . Their work should be applauded because many studies of rodent islets may be applicable to man but this should never be assumed. Our own data has shown previously the marked discrepancies between the capacity of fetal mouse pancreas and human fetal pancreas to secrete insulin in response to a glucose stimulus [2, 3] .
Subsequent to our finding that human fetal pancreas was unresponsive to glucose, and that a single defect in early glycolysis or deficiency of cyclic AMP was unlikely [3] , a defect in glucose oxidation
